Antimicrobial therapy in the myelo- and immuno-compromised patient.
D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D017053:Infection Control; D007239:Infections / Q000276:immunology; D010347:Patient Care Planning; D013997:Time Factors
D000900:Anti-Bacterial Agents